InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 1.63 USD 12.41% Market Closed
Updated: May 19, 2024

InflaRx NV
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InflaRx NV
Operating Expenses Peer Comparison

Comparables:
BNTX
MOR
CVAC
IMTX
BIO

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
InflaRx NV
NASDAQ:IFRX
Operating Expenses
-€46.2m
CAGR 3-Years
-13%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Operating Expenses
-€2.3B
CAGR 3-Years
-66%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Operating Expenses
-€611.1m
CAGR 3-Years
-25%
CAGR 5-Years
-37%
CAGR 10-Years
-25%
CureVac NV
NASDAQ:CVAC
Operating Expenses
-€207.2m
CAGR 3-Years
-13%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Operating Expenses
-€155.7m
CAGR 3-Years
-16%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Expenses
-€174.6m
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-1%

See Also

What is InflaRx NV's Operating Expenses?
Operating Expenses
-46.2m EUR

Based on the financial report for Mar 31, 2024, InflaRx NV's Operating Expenses amounts to -46.2m EUR.

What is InflaRx NV's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-3%

Over the last year, the Operating Expenses growth was -65%. The average annual Operating Expenses growth rates for InflaRx NV have been -13% over the past three years , -3% over the past five years .